The research is published in the April issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, in a special topic issue focused on antimicrobial stewardship. Antimicrobial stewardship programs and interventions help prescribers know when antibiotics are needed and what the best treatment choices are for a particular patient.
According to the study, which evaluated a seven-year antimicrobial stewardship program at University of Maryland Medical Center (UMMC), the program eliminated $3 million from the hospital's annual budget for antimicrobials by its third year. After seven years, it had cut antibiotic spending per-patient day nearly in half. Cost savings were evident across hospital departments, including the cancer center, trauma center, surgical and medical intensive care units and transplant service.
Importantly, these savings did not compromise quality of patient care. The study found no increases in mortality, length of stay, or readmission to the hospital.
Despite its success, however, the program was terminated in 2008 in favor of providing more infectious diseases consults. The consequences of that decision were immediate. Antimicrobial costs increased by 32 percent—nearly $2 million—within two years after the program was terminated according to the research.
"Our results clearly show that an antimicrobial stewardship program like the one at UMMC is safe, effective, and makes good financial sense," said Harold Standiford, MD, medical director for antimicrobial effectiveness at UMMC and the study's lead author.
The central component of the UMMC program was an antimicrobial monitoring team (AMT) that included an infectious diseases physician and a clinical pharmacist with infectious diseases training. The AMT made daily rounds and provided real time monitoring of antimicrobial use with active intervention and education when changes in treatment were recommended. The team also provided leadership in discussions about changes to antibiotics on the formulary and the development of relative policies and guidelines.
When the program was terminated, the AMT was disbanded in favor of additional personnel who provided infectious diseases consults throughout the hospital including in areas caring for highly specialized patients. It was believed that these additional personnel, though decentralized, would provide appropriate stewardship and render the AMT redundant. That decision proved costly, however, and in light of this study's findings the medical center has restarted a modified stewardship program including an AMT.
"Our research shows that investing in stewardship not only helps preserve our dwindling antibiotic tools, it can also help to eliminate wasteful healthcare spending," Dr. Standiford said. "We believe it's an important lesson to keep in mind when considering the allocation of resources to stewardship programs."Harold C. Standiford, Shannon Chan, Megan Tripoli, Elizabeth Weekes, Graeme N Forrest, "Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost Analysis Before, During, and After a 7-Year Program." Infection Control and Hospital Epidemiology 33:4 (Special Topic Issue: Antimicrobial Stewardship, April 2012).
SHEA is a professional society representing more than 2,000 physicians and other healthcare professionals around the world with expertise in healthcare epidemiology and infection prevention and control. SHEA's mission is to prevent and control healthcare-associated infections and advance the field of healthcare epidemiology. The society leads this field by promoting science and research and providing high-quality education and training in epidemiologic methods and prevention strategies. SHEA upholds the value and critical contributions of healthcare epidemiology to improving patient care and healthcare worker safety in all healthcare settings. Visit SHEA online at www.shea-online.org
Tamara Moore | EurekAlert!
Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy